GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (OSTO:CANTA) » Definitions » Accounts Payable

Cantargia AB (OSTO:CANTA) Accounts Payable : kr5.70 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cantargia AB Accounts Payable?

Cantargia AB's Accounts Payable for the quarter that ended in Sep. 2024 was kr5.70 Mil.

Cantargia AB's quarterly Accounts Payable declined from Mar. 2024 (kr19.80 Mil) to Jun. 2024 (kr11.55 Mil) and declined from Jun. 2024 (kr11.55 Mil) to Sep. 2024 (kr5.70 Mil).

Cantargia AB's annual Accounts Payable increased from Dec. 2021 (kr34.51 Mil) to Dec. 2022 (kr37.91 Mil) but then declined from Dec. 2022 (kr37.91 Mil) to Dec. 2023 (kr23.17 Mil).

Cantargia AB Accounts Payable Historical Data

The historical data trend for Cantargia AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantargia AB Accounts Payable Chart

Cantargia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.62 10.68 34.51 37.91 23.17

Cantargia AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.15 23.17 19.80 11.55 5.70

Cantargia AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Cantargia AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of Cantargia AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantargia AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (OSTO:CANTA) » Definitions » Accounts Payable
Comparable Companies
OSTO:IMMU OSTO:SYNACT OSTO:INIT OSTO:ISOFOL OSTO:FLUO XSAT:CESSA OSTO:ONCO OSTO:MVIR OSTO:ALZ XSAT:CURAS VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
7V3:Germany
Address
Scheelevagen 27, Lund, SWE, SE-223 63
Website
https://www.cantargia.com
Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.

Cantargia AB Headlines

No Headlines